UroToday - Prostate Cancer

Home

Prostate Cancer

UroToday's Prostate Cancer section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of prostate cancer. Also available are conference coverage for all timely prostate cancer science, streaming media presentations, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind Regards,
Christopher P. Evans MD,
Associate Section Editor of Oncology/Prostate Cancer,
UroToday International Journal

Display

results per page

Results 31 - 60 of 5471

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Incidence of cancer in Finnish families with clinically aggressive and nonaggressive prostate cancer - Abstract
Tuesday, 17 November 2009
Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere, Tampere, Finland.
read more

Enhanced sensitivity to androgen withdrawal due to overexpression of interleukin-6 in androgen-dependent human prostate cancer LNCaP cells - Abstract
Tuesday, 17 November 2009
Division of Urology, Department of Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
read more

The effect of Gleason score on the predictive value of prostate-specific antigen doubling time - Abstract
Tuesday, 17 November 2009
Department of Urology, and Division of Biostatistics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.
read more

EDAP appoints top U.S. urologist to lead FDA HIFU clinical trial
Monday, 16 November 2009
LYON, FRANCE (Press Release) - November 16, 2009
read more

Editorial - Natural history of persistently elevated prostate specific antigen after radical prostatectomy: Results from the SEARCH database
Monday, 16 November 2009
BERKELEY, CA (UroToday.com) - A prostate specific antigen (PSA) level that does not nadir after radical prostatectomy (RP) suggests residual benign or malignant local disease, or metastatic disease that occurred prior to surgery.
Login to read more...

Correlation of thermocouple data with voiding function after prostate cryoablation - Abstract
Monday, 16 November 2009
Department of Regional Urology, Cleveland Clinic Fairview Cancer Center, Glickman Urological and Kidney Institute, Cleveland, OH.
read more

Radical radiotherapy for prostate cancer is the 'only way to go' - Abstract
Monday, 16 November 2009
Cedars-Sinai Medical Center Los Angeles, California, USA.
read more

Well-done meat intake, heterocyclic amine exposure, and cancer risk - Abstract
Monday, 16 November 2009
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN 37203-1738, USA.
read more

FTIR microspectroscopy for improved prostate cancer diagnosis - Abstract
Monday, 16 November 2009
Departments of Pediatrics, Microbiology & Immunology, and Radiology: Molecular Imaging Program at Stanford (MIPS) and the BioX Program, Stanford University, 318 Campus Drive, Stanford, CA 94305, USA.
read more

Expression and localization of hypoxia proteins in prostate cancer: Prognostic implications after radical prostatectomy - Abstract
Monday, 16 November 2009
Department of Urology, University Medical Center Utrecht, The Netherlands.
read more

Relationship between prostate-specific antigen and hematocrit: Does hemodilution lead to lower PSA concentrations in men with a higher body mass index? - Abstract
Monday, 16 November 2009
Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo, Japan.
read more

Analysis of continence rates following robot-assisted radical prostatectomy: Strict leak-free and pad-free continence - Abstract
Monday, 16 November 2009
Section of Urology, Department of Surgery, University of Chicago Medical Center, Chicago, Illinois.
read more

Serum level of clusterin and its density in men with prostate cancer as novel biomarkers reflecting disease extension - Abstract
Monday, 16 November 2009
Division of Urology, Kobe University, Graduate School of Medicine, Kobe, Japan.
read more

Justification for inter-fraction correction of catheter movement in fractionated high dose-rate brachytherapy treatment of prostate cancer - Abstract
Monday, 16 November 2009
Mount Vernon Centre for Cancer Treatment, Middlesex, UK.
read more

Laparoendoscopic single-site surgery: Initial hundred patients - Abstract
Monday, 16 November 2009
Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio 44196, USA
read more

Beyond the Abstract - Anxiety and distress during active surveillance for early prostate cancer, by Roderick C.N. van den Bergh, MD, et al.
Friday, 13 November 2009
BERKELEY, CA (UroToday.com) - The present study found that the majority of men with early prostate cancer (PC) included in a protocol-based program for active surveillance (AS) show favorable anxiety and distress scores when compared to reference values and to groups of patients with PC who underwent other treatments.
Login to read more...

Should prostate specific antigen be adjusted for body mass index? Data from the Baltimore Longitudinal Study of Aging - Abstract
Friday, 13 November 2009
The James Buchanan Brady Urological Institute, The Johns Hopkins Medical Institutions and National Institute on Aging, National Institutes of Health Clinical Research Branch, Baltimore, Maryland.
read more

Post radiotherapy leiomyosarcoma of the prostate: Can radiation therapy induce a secondary cancer? A case report - Abstract
Friday, 13 November 2009
John Theuer Cancer Center, Hackensack University Medical Center, 30 Prospect Avenue, Hackensack, NJ 07601, USA.
read more

Clinical and pathologic predictors of Gleason sum upgrading in patients after radical prostatectomy: Results from a single institution series - Abstract
Friday, 13 November 2009
Department of Urology, University Hospital Grosshadern, Ludwig-Maximilians University, Munich, Germany.
read more

Laparoscopic mesh herniorrhaphy: Impact on outcomes associated with radical retropubic prostatectomy - Abstract
Friday, 13 November 2009
Department of Urology, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
read more

Comparison of prostate cancer tumor volume and percent cancer in prediction of biochemical recurrence and cancer specific survival - Abstract
Friday, 13 November 2009
Department of Urology, Stanford University Medical Center, Stanford, CA 94305, USA.
read more

Docetaxel in combination with prednisolone for hormone refractory prostate cancer - Abstract
Friday, 13 November 2009
Department of Urology, Keio University School of Medicine, Department of Urology, International University of Health and Welfare Mita Hospital, Department of Urology, Tokyo Medical University, Tokyo, Japan .
read more

Predictors of new screening for African American men participating in a prostate cancer educational program - Abstract
Friday, 13 November 2009
Tennessee State University, Nashville, TN, USA.
read more

High prevalence of prostatic neoplasia in Australian men - Abstract
Friday, 13 November 2009
Department of Forensic Medicine, Sydney South West Area Health Service, University of Sydney, Sydney, New South Wales, Australia
read more

Beyond the Abstract - Is the incidence of uretero-intestinal anastomotic stricture increased in patients undergoing radical cystectomy with previous pelvic radiation? by Devendar Katkoori, MD and Murugesan Manoharan, MD
Thursday, 12 November 2009
BERKELEY, CA (UroToday.com) - Radical cystectomy (RC) with urinary diversion in the setting of prior radiation therapy (RT) is historically associated with a higher incidence of ureterointestinal anastomotic stricture (UIAS) and anastomotic leak.
Login to read more...

Operator is an independent predictor of detecting prostate cancer at transrectal ultrasound guided prostate biopsy - Abstract
Thursday, 12 November 2009
Urology, University Health Network, University of Toronto, Princess Margaret Hospital, Toronto, Ontario, Canada.
read more

Validation in a multiple urology practice cohort of the prostate cancer prevention trial calculator for predicting prostate cancer detection - Abstract
Thursday, 12 November 2009
Division of Urology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
read more

Clinicopathological behavior of single focus prostate adenocarcinoma - Abstract
Thursday, 12 November 2009
Urology Service, Walter Reed Army Medical Center, Washington, D.C.
read more

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults - Abstract
Thursday, 12 November 2009
Department of Medical Oncology, Centre Léon-Bérard, Lyon, France; Claude-Bernard Lyon 1 University, Lyon, France.
read more

Clinical interpretation of the Expanded Prostate Cancer Index Composite-Short Form sexual summary score - Abstract
Thursday, 12 November 2009
Department of Urology, Division of Urologic Oncology, University of Michigan, Ann Arbor, Michigan.
read more

Focus on Prostate Cancer

Focus on Prostate Cancer condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.






Technology Centers Prostate Cancer - Prognostic Nomograms - by Ricardo Sanchez-Ortiz, MD EAU Position Statement on Screening for Prostate Cancer - News Release Anxiety and distress during active surveillance for early prostate cancer - by Roderick C.N. van den Bergh, MD, et al. Degarelix: A new approach for the treatment of prostate cancer - by Bo-Eric Persson, MD A 64-year-old man with low-risk prostate cancer: Review of prostate cancer treatment - by Sandip M. Prasad, MD and Martin G. Sanda, MD - Editor's Pick Apocrine Sweat Gland Obstruction by Antiperspirants Allowing Transdermal Absorption of Cutaneous Generated Hormones and Pheromones as a Link to the Observed Incidence Rates of Breast and Prostate Cancer in the 20th Century - by Kris G. McGrath, MD A Novel Communication Role for CYP17A1 in the Progression of Castration-Resistant Prostate Cancer - by Emma Tomlinson Guns, PhD Phase I/II Trial of Docetaxel and Concurrent Radiation Therapy in Localized High Risk Prostate Cancer (AGUSG 03-10) - by Michael Perrotti, MD, et al. A 1-Year, Open Label, Randomized Phase II Dose Finding Study of Degarelix for the Treatment of Prostate Cancer in North America - by Marc Gittelman, MD - Editor's Pick Management of the Side Effects of Androgen Deprivation Therapy in Men with Prostate Cancer - by Thomas W Flaig, MD Sexually Transmissible Infections and Prostate Cancer Risk - by Wen-Yi Huang, PhD, MSPH, et al. Serum Calcium and Incident and Fatal Prostate Cancer in the National Health and Nutrition Examination Survey - by Gary G. Schwartz, PhD, MPH - Editor's Pick Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005 - by Christopher P. Evans, MD, FACS Periurethral suspension stitch during robot-assisted laparoscopic radical prostatectomy: Description of the technique and continence outcomes - by Christopher P. Evans, MD, FACS Duplicate presentations on prostate cancer at American Urological Association and European Association of Urology annual meetings - by Christopher P. Evans, MD, FACS High-Dose-Rate Brachytherapy for Localized Prostate Adenocarcinoma Post Abdominoperineal Resection of the Rectum and Pelvic Irradiation: Technique and Experience - by Christopher P. Evans, MD, FACS Impact of Surgeon and Hospital Volume on Outcomes of Radical Prostatectomy - by Christopher P. Evans, MD, FACS PCPT: Evidence That Finasteride Reduces Risk of Most Frequently Detected Intermediate- And High-Grade (Gleason Score 6 and 7) Cancer - by Christopher P. Evans, MD, FACS A Broader Role for 5ARIs in Prostate Disease? Existing Evidence and Emerging Benefits - by Christopher P. Evans, MD, FACS Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study - by Christopher P. Evans, MD, FACS - Editor's Pick Predicting Prostate Cancer Risk Through Incorporation of Prostate Cancer Gene 3 - by Christopher P. Evans, MD, FACS HIV and Prostate Cancer: A Systematic Review of the Literature - by Christopher P. Evans, MD, FACS - Editor's Pick Obesity-Related Plasma Hemodilution and PSA Concentration among Men with Prostate Cancer - by Christopher P. Evans, MD, FACS - Editor's Pick Androgen Deprivation Therapy for Localized Prostate Cancer and the Risk of Cardiovascular Mortality - by Christopher P. Evans, MD, FACS Editor's Pick Patient Response to Total Intravenous Sedation (TIVS) for Outpatient Ultrasound-Guided Prostate Biopsy - by Ahmed Al-Sameraaii, MD, et al. A Four-Gene Expression Signature for Prostate Cancer Cells Consisting of UAP1, PDLIM5, IMPDH2, and HSPD1 - by Herbert A. Fritsche, PhD, et al. Peripheral Zone Sonographic Changes of the Prostate - by El-Housseiny Ismail Ibrahiem (El- Zalouey), MD, et al. Successful Early Prostate Cancer Screening by Three-Dimensional Color Doppler Imaging-Transrectal Ultrasound: A Prospective Study - by Walter Merkle, MD Mechanism of Neuroendocrine Differentiation in Prostate Cancer: BMP6-Macrophage-IL6 Loop via Obligatory Involvement of Both Smad-Dependent and -Independent Pathway - by Isaac Yi Kim, MD, et al. Secondary Therapy In Localized Prostate Cancer: Results From The Prostate Cancer Outcomes Study - by David F. Penson, MD, et al. Prostate Cancer Diagnosis in High Risk Patients The Finasteride Challenge Trial - by Bernd J Schmitz-Dräger, MD, et al. Key targets of hormonal treatment of prostate cancer. Part 2: The androgen receptor and 5α-reductase Robotic-assisted radical prostatectomy: A review of current outcomes Locally advanced prostate cancer: the role of surgical management Key targets of hormonal treatment of prostate cancer. Part 1: The androgen receptor and steroidogenic pathways Prostate Cancer: A Serious Disease Suitable for Prevention Prostate-Specific Antigen Kinetics in Localized and Advanced Prostate Cancer
SIU Satellite Symposium 2007 Advanced Prostate Cancer: Current Status, Controversies, and Future Directions By Fred Saad, MD, FRCS Bone Metastases Module By Edward Chow MBBS, PhD, FRCPC Accompanying Case Studies A 64 year old retired pharmacist presents to his primary care physician with complaints of urinary urgency and frequency of 6 months duration and of increasingly severe low back and right hip pain of 3 months duration. A 73 year old retired commericial fisherman was diagnosed 3 years ago with a Stage IV [Gleason 3 + 3(6)] prostate cancer with bone being the only site of metastases. A 55 year old woman presents to her primary care physician with occasional gross painless hematuria for 4 months. A 59 year old male had a diagnosis of renal cell carcinoma of the left kidney made 2 years ago after presenting with flank pain and hematuria.
9th International Prostate Forum - View Session Highlights Evaluation of the prostate cancer prevention trial risk calculator in a high-risk screening population - Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting What to do when the pathologist reports "positive margins" - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting Open prostatectomy is best - Multimedia Lecture by William J. Catalona, MD from the AUA NY Section 107th Annual Meeting One year result of the retrourethral transobturator sling for the minimal-invasive treatment of male stress incontinence after radical prostatectomy - Slide Presentation by Christian G. Stief, MD at the Urological Research Society (URS) 25th Annual Meeting Prostate cancer detection using a novel computerized three-dimensional prostate biopsy template (Targetscan™): Results of a multicenter prospective data registry - Slide Presentation - Slide Presentation by Samir S. Taneja, MD at the Urological Research Society (URS) 25th Annual Meeting VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Session Highlights VI Maratona Urológica do Rio de Janeiro - View Prostate Cancer Slide Presentations American Society of Clinical Oncology (ASCO) 2009 Annual Meeting - View Prostate Cancer Session Highlights American Urological Association (AUA) 2009 Annual Meeting - View Prostate Cancer Session Highlights Post Prostatectomy Incontinence Study - SUFU 2009 - Highlight of a Presentation by Victor W. Nitti, MD Open, Laparoscopic and Robotic Prostatectomy: Much Ado About Nothing? - WUF 2009 - Lecture Presented by Christopher P. Evans, MD, FACS Society of Urologic Oncology (SUO) 9th Annual Winter Meeting - View Prostate Cancer Session Highlights Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Options in Prostate Cancer Surgery: Perineal Prostatectomy in the Age of Minimally Invasive Surgery - Masters in Urology 2008 - Slide Presentation Advances in the Treatment of Hormone Refractory Prostate Cancer - Masters in Urology 2008 - Session Highlight The American Society for Therapeutic Radiology and Oncology - 50th Annual Meeting - ASTRO 2008 - Prostate Cancer Abstracts American Society of Clinical Oncology - 44th Annual Meeting - ASCO 2008 - Prostate Cancer Abstracts The American Urological Association 2008 Annual Meeting - AUA 2008 Prostate Cancer Session Highlights Engineering and Urology Society - 23rd Annual Meeting - EUS 2008 - Prostate Cancer Abstracts